|
|
Volumn 22, Issue 1, 2001, Pages 49-55
|
|
The closeout process for a clinical trial terminated early for lagging enrollment and inadequate follow-up
a
a
WESTAT
(United States)
|
|
Author keywords
Administrative termination; Closeout; Failed accrual; Inadequate follow up
|
|
Indexed keywords
ALPHA INTERFERON;
PROTEINASE INHIBITOR;
ARTICLE;
CLINICAL RESEARCH;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
FOLLOW UP;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LYMPHOCYTE COUNT;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
PATIENT SCHEDULING;
RANDOMIZED CONTROLLED TRIAL;
REIMBURSEMENT;
TOXICITY;
TREATMENT OUTCOME;
ADMINISTRATION, ORAL;
ADULT;
CD4 LYMPHOCYTE COUNT;
DATA COLLECTION;
DOUBLE-BLIND METHOD;
FEMALE;
FOLLOW-UP STUDIES;
HIV INFECTIONS;
HUMANS;
INTERFERON-ALPHA;
MALE;
OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE);
PATIENT SELECTION;
SURVIVAL RATE;
TREATMENT FAILURE;
|
|
EID: 0035154161
PISSN: 01972456
EISSN: None
Source Type: Journal
DOI: 10.1016/S0197-2456(00)00111-2 Document Type: Article |
|
Times cited : (10)
|
|
References (1)
|
